Ming Li
Endocrinology, Diabetes & Metabolism · San Jose, CANPI 1982702056
Payments from drug & device makers
Across 176 payments — averaging $21.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$628
- Novo Nordisk$473
- AstraZeneca$399
- Boehringer Ingelheim$358
- Sanofi-aventis U.S. LLC$343
- AbbVie$266
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,77199%
- Education$321%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 28 | $628 |
| Novo Nordisk | 25 | $473 |
| AstraZeneca | 20 | $399 |
| Boehringer Ingelheim | 15 | $358 |
| Sanofi-aventis U.S. LLC | 17 | $343 |
| AbbVie | 14 | $266 |
| Johnson & Johnson(2 entities) | 9 | $203 |
| Regeneron Healthcare Solutions, Inc. | 6 | $182 |
| Merck | 7 | $154 |
| Amgen | 7 | $137 |
| Xeris Pharmaceuticals, Inc. | 5 | $104 |
| Dexcom, Inc. | 3 | $95 |
| Corcept Therapeutics | 4 | $94 |
| Kowa Pharmaceuticals America, Inc. | 3 | $69 |
| Legend Biotech USA Inc. | 2 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| Pfizer | 1 | $27 |
| Genmab U.S., Inc. | 1 | $25 |
| Abbott | 1 | $23 |
| Blueprint Medicines Corporation | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| EUSA Pharma (US) LLC | 1 | $20 |
| Recordati_rare_diseases_inc. | 1 | $20 |
| Geron Corporation | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
How this compares
$3,803 in reported general payments places this provider in the 60th percentile of 952 endocrinology, diabetes & metabolism providers in California.
See all endocrinology, diabetes & metabolism providers in California →
Other endocrinology, diabetes & metabolism in San Jose
- Joselito CabaccanSan Jose$1.4M
- Jerrold OlefskySan Diego$26.5M
- Mark ChristiansenWalnut Creek$22.9M
- Timothy BaileyEscondido$22.3M
- Stanley HsiaLos Angeles$19.8M
- Juan FriasSan Diego$14.1M
- Paul NorwoodFresno$6.2M
- Athena Philis-Tsimikasla Jolla$6M
- David AhnNewport Beach$5.8M
- Shlomo MelmedLos Angeles$3.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.